Law & policy

Latest content

State of inventiveness in Europe

The region is lagging behind its global peers in invention productivity but there are ways this gulf can be crossed

24 February 2023

Vidal reveals perspective on UPC, SEPs and competition with China

In the second part of IAM’s exclusive interview with USPTO Director Kathi Vidal, she shares her thoughts on international patent issues

23 February 2023

The power of the unitary patent should be the UPC’s biggest draw

While the litigation system is attracting most of the attention, the new right has the potential to be more valuable than anything granted anywhere else in the world

23 February 2023

Exclusive: Vidal on discretionary denials, director review changes and Section 101 action

In the first of a two-part interview with IAM, the USPTO director opened up about the most pressing issues facing the US patent system

22 February 2023

Unitary SPCs necessary to attract pharma to UPC/UP system, says Bayer IP chief

Joerg Thomaier also shares his thoughts on the UPC and EPO patent quality in an exclusive IAM interview

22 February 2023

Patent damages precedent makes waves in component suppliers’ negotiations

After Caltech v Broadcom, suppliers may face higher royalties for infringing components used in downstream products

22 February 2023

Critical 2022 high court decisions shaping the Indian prosecution landscape

The abolishment of the IPAB in 2021 sparked doubts about whether India’s high courts could handle the heavy case load. However, the Delhi High Court continues to prove its ability to stand strong as it rules on claim amendments and divisional applications.

22 February 2023

CJEU ruling on preliminary injunctions sets regional courts on different paths

Patent litigators in Germany are feeling the effects of Phoenix Contact. While it was widely anticipated that German courts might alter their jurisprudence as a result, Düsseldorf and Munich’s regional courts are taking noticeably diverging approaches now that the first decisions on the matter have been published.

22 February 2023

Indian patent office budget hike bodes well but spending is the real issue

A 15% boost could help bolster staffing and shorten timelines but smarter use of funds is essential

20 February 2023

Amgen v Sanofi highlights growing ambiguity of pharma IP strategies

Saturday Opinion: SCOTUS enablement review has exposed divisions among innovative life sciences companies

18 February 2023

Unlock unlimited access to all IAM content